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Abstract  
This review focuses on the studies and opinions around issues of transition from the BPharm to the PharmD degree in the U.S., Japan, 
South Korea, Pakistan and Thailand. 
The transition to the clinically orientated PharmD degree in many countries was seen to be a means of developing the profession. 
However, some countries have both clinically-oriented and pharmaceutical sciences-oriented PharmD programme that are designed to 
meet the needs of their countries. Each country created a different process to handle the transition to an all-PharmD programme, but 
mostly had the process of school accreditation mandated by the regulatory bodies. The main barrier to the transition in most of the 
countries was the issue of educational quality. A set of indicators is needed to measure and monitor the impact/outcome of the 
PharmD degree.  
Each country has different needs due to the different contexts of health care systems and the scope of pharmacy practice. In order to 
increase their chances of benefiting from the new programme, academic leaders should critically assess their countries’ needs before 
deciding to adopt a PharmD programme. 
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INTRODUCTION 
The Doctor of Pharmacy (PharmD) is a professional 
doctorate degree, also known as a clinical doctorate - a 
term only used in the health professions.
1
 The professional 
doctorate degree emphasises practice competencies, which 
is different from an academic doctorate, such as Doctor of 
Philosophy (PhD) that focuses on knowledge or original 
research production.1 The United States was the first 
country that has moved to a 6-year PharmD degree as the 
sole credential for the professional pharmacy programme 
and focuses mainly on clinical pharmacy.2 There is an 
increasing global trend for example  in countries towards  
PharmD degree education.3-9 The list of countries that 
transitioned from the BPharm to the PharmD degree, as 
their entry-level qualification are as follows, U.S., Canada 
(plan to offer an all-PharmD in 2020), Hungary, Italy, Japan, 
South Korea, Pakistan, Saudi Arabia, Thailand, Benin, 
Cameroon, Republic of Congo, Senegal, Tunisia, Nigeria and 
Gana.5-9 This paper aims to review the key publications 
demonstrating the opinions around issues of transition 
from the BPharm to the PharmD degree in the five selected 
countries, which are the U.S., Japan, South Korea, Pakistan 
and Thailand. 
The countries were chosen because there were a number 
of publications about the transition available. The basic 
information regarding the pharmacy workforce and 
education in those selected countries is presented in Table 
1. The most popular area of practice in the developed 
countries is community pharmacy, due to the structure of 
their health care systems that need a high number of 
pharmacists in such pharmacies. On the other hand, the 
popular area of practice in Pakistan is the pharmaceutical 
industry because of the successful pharmaceutical industry 
in Pakistan.10 Thailand has hospital pharmacy as the most 
popular area of practice, due to the public hospitals being 
the country’s main healthcare facilities.11 
Educational pathways to become a pharmacist in the five 
selected countries  
The pharmacy educational systems are similar in course 
length most are approximately 6 years if pre-entry 
standards and internships are included (Table 2).3,4,12-16 All 
countries have a similar education system to cater for those 
who wish to become a pharmacist: the students enter from 
secondary school except for the U.S. and South Korea 
where school leaving qualifications are lower and  entry is 
after a minimum 2 years at the university, followed by a 4-
year pharmacy course with one year training experience 
and then a licensure examination.13-15 All countries require 
registration assessment of new pharmacists or their 
national licensure examination. 
Scope of pharmacy practice in the five selected countries 
Pharmacists in all countries provide clinical pharmacy 
services but at different levels of implementation; for 
example, pharmacists in developed countries have many 
supporting systems for the implementation of 
pharmaceutical care practice. On the other hand, in 
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developing countries pharmaceutical care implementation 
still encounters a number of challenges, including the 
absence of a recognized reimbursement system.17,18 
Pharmacists in the U.S. can be given the authority to be 
supplementary or independent prescribers via collaborative 
practice agreements that depend on state regulations; 
while pharmacists in Japan, South Korea, Pakistan, and 
Thailand have prescribing authority for ‘pharmacist only 
medicines (POM)’ and the over-the counter (OTC) 
medicines for the symptomatic treatment of minor 
conditions. 
 
THE TRANSITION FROM THE BPHARM TO THE 
PHARMD DEGREE  
The key publications demonstrating the opinions evolving 
around the issues of transition from the BPharm to the 
PharmD degree have been reviewed. There are four main 
issues that consistently emerged as follows;  
1. Needs and context: It seems that the intention of the 
transition to the PharmD degree in many countries was to 
use pharmacy education as a way to guide the future of the 
profession, especially shifting to a more clinically oriented 
degree.4,19 On the other hand, Pakistan, South Korea and 
Thailand needed to expand their pharmacists’ roles in 
clinical pharmacy, as well as meeting the high demand for 
pharmacists in the pharmaceutical industry.16,20-24   
It was suggested that the bachelor degree was still needed 
and should be continued as a basic degree programme, in 
order to develop pharmacists who have knowledge and 
skills to work in non-direct patient care areas like the 
pharmaceutical industry and marketing.21,22,24  
2. Process: The process of the transition from the BPharm 
to the PharmD has created similar situations among several 
countries as follows:  
1) Debating about the transition:  There were debates 
about the transition from the BPharm to the PharmD 
degree for a long period of time in order to establish a 
consensus at the national level.19  
2) Mandating by the regulatory bodies: Each country had 
their regulatory bodies who mandated the PharmD 
programme as the entry-level pharmacy programme, by 
moving toward some sort of standardised credentialing 
methods.2,19  For example, the curriculum must have 
been revised to fit the new PharmD programme in order 
to receive its accreditation or to produce pharmacy 
graduates who are eligible to sit for the licensure 
examination.2,26,27 
3) Supportive regulations concerning the provision of 
pharmaceutical care in practice settings: In some 
countries, there are factors that support pharmacists to 
take up their new roles in direct patient care activities. 
For example, in the U.S., the pharmaceutical care 
service called medication therapy management (MTM), 
has been codified into law, and Medicare Part D 
providers are required to offered MTM services to a 
specific subset of patients.19,25,28-30 This situation differs 
from many developing countries, which have changed to 
the PharmD degree, that still have no supporting 
regulations and often no professional fee framework to 
reward pharmacists for making high-risk clinical 
decisions.4,31,32 
3. Barriers to the transition: The transition from bachelor 
degree to doctoral level, in most of countries raised 
concerns about education quality.32 Most developing 
Table 1. Basic information, education and training in the five selected countries that moved to an all-PharmD degree 
Characteristics U.S.
45,71,72
 Japan
51-53,55,73
 South Korea
20,74
 Pakistan
6,10,75-77
 Thailand
77,78
 
General aspects 
Population (millions) 273 128 49.8 176 67 
GDP per capita (USD) (2013) 54,353 42,983 18,373 4,700 14,400 
Number of licensed pharmacists (per 
10,000 of population)  
249,642 (9) 276,517 (21) 53,492 (6.5) 12,000 (0.7) 28,272 (4.2) 
Pharmacy workforce by practice
79,80 
 
C
a
  65%, H
b
  25%,  
O
c
 10% 
C 49.6%, H 19.4%, 
I
d
 11.9%, O 19.1% 
C  28.6%, I 21%, 
H  18.3%, O 32.1% 
I 55%, C 10%, 
H 10%, O 25% 
H 40%, C 17%, 
I 10%, O 33% 
Community pharmacies
79
 37,539 71,970 20,633 80,000 11,592 
Re-licensure required Requirements vary by 
state 
No renewal system in 
pharmacy license 
N/A N/A Renewed every 5 years 
Pharmacy education 
No. of pharmacy institutions
6
 129 74 35 43 19 
No. of pharmacy technicians institution
79
 700 0 0 9 17 
Pharmacy graduate per year
6
 12,719 9,912 1,372 4,000 1,680 
Year that transition to an all-PharmD 
programme has been started 
2000 2006 2009 2004 2010 
Academic programme, length (years) PharmD
e
, 6
f
, 4
g
 Bachelor, 6 Bachelor, 6 PharmD, 5 PharmD, 6 
Practice training
6
 C, H, O (1,000-1,800  
practice hours) 
C, H (6 months) N/A C, H 
 
C, H, I, O (2,000 practice 
hours) 
National licensing exam Required Required Required Required Required 
The programme that bridge the 
academic gap between 4-, 5- and 6-
year pharmacy programme 
Non-traditional 
PharmD programme 
The new curriculum- 
support training 
Master degree 
programme in 
clinical pharmacy 
N/A Master degree 
programme in clinical 
pharmacy, 
Residency training 
programme 
a
C=Community pharmacy; 
b
H= Hospital pharmacy; 
 c
O=Others;
 d
I=Industrial pharmacy; 
e
nearly half of students hold a bachelor or higher degrees; 
f 
for PharmD 
programme with no pre-pharmacy requirements for admission; 
g
for PharmD programme that requires at least 2-years of specific pre-professional (undergraduate) 
coursework prior to 4-academic year of professional study. 
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countries may lack such crucial factors as experienced 
clinical academic staff, competent preceptors, collaboration 
with hospitals. Other challenges are likely to include 
insufficient infrastructure, and economic resources to 
provide adequate internships, all of which might affect the 
quality of pharmacists’ education.4,33 
4. Impact/outcome: There is still insufficient information to 
develop a definite argument to support a relationship 
between success indicators and the introduction to the 
PharmD degree.4,34 Anderson and Futter suggested that 
there should be a set of indicators to measure and monitor 
the impact of the PharmD degree.4 In the following section, 
the transition from the BPharm to the PharmD programme 
or similar programme in the U.S., Japan, South Korea, 
Pakistan and Thailand has been reviewed. 
 
THE UNITED STATES OF AMERICA 
Need for the change 
The U.S. pharmacy profession decided to move to an all-
PharmD programme over 20 years ago, in an effort to 
enhance pharmacists’ competencies and reflect growth in 
the knowledge base of the profession.1,35 There was a need 
to incorporate new competencies into the pharmacy 
curriculum and a need to provide robust pharmaceutical 
care, together with the potential for improved economic 
outcomes.19  
Process of the transition to the PharmD degree 
The origin of the debate over whether to offer the entry 
level PharmD as the sole professional degree began back in 
1948, when the American Council on Education (ACE) 
recommended that the professional pharmacy curriculum 
should be a 6-year programme. In 1989, 56% of U.S. 
pharmacy schools still only offered the bachelor degree, 
14% offered the PharmD degree and 30% offered both 
degrees.  
The American Association of Colleges of Pharmacy (AACP) 
President William Miller appointed a task force, which was 
termed The AACP Commission of Implement Change in 
Pharmaceutical Education, to develop recommendations to 
guide pharmacy education to meet the demands of the 
profession, the health care system and the society.25,36,37   
In 1989, the Accreditation Council for Pharmacy Education 
(ACPE), the body that sets educational standards and 
accredits colleges of pharmacy, stated that its intent was to 
accredit only PharmD degree programmes as the entry-
level degree into the pharmacy profession; suggesting the 
year 2000 as a probable target date.25 This declaration 
drove much discourse among educators who were doubtful 
of obtaining adequate resources to add another year into 
the curricula. Concern was also expressed over the 
practitioners: in particular fearful that bachelor 
practitioners would be disenfranchised if pharmacy schools 
produced only PharmD graduates.25 Debates about the 
PharmD as the entry-level degree have continued for 
approximately 40 years but the issue was finally resolved in 
July 1992, at the annual meeting of the AACP.25 The 
delegates voted overwhelmingly to endorse the PharmD 
degree as the sole degree leading into the practice of 
pharmacy.25  In 1997 with the publication of Standards 
2000, the ACPE put in place the requirement that all 
pharmacy schools develop a plan for transitioning from two 
degrees to one degree by July 1, 2000.19 Then, all schools 
Table 2. Educational pathways to become a pharmacist in the five selected countries that transition from the BPharm to PharmD programme  
(Adapted with permission from Sripanidkulchai 2012)
13-16
 
Approximate age 
of learner 
5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 
Approximate 
grade 
1 2 3 4 5 6 7 8 9 10 11 12  
US 
(6-year PharmD) 
Primary school Secondary school 2-year 
prerequisites or 
obtaining a 
transferable 
bachelors’ 
degree 
pharmacy 
4-year School of Pharmacy, 
including clerkship 1,000-1,800 
practice hours 
-IPPE
a
 300 hours during first 3 
years of course 
-APPE
b
 36 weeks in the fourth 
year 
State Board 
exam 
Japan 
(6-year BPharm) 
Primary school Junior High 
school 
High school 6-year BPharm, including 6 months internship 
(Prior to start outside practice: students have to 
take common exam at  school (CBT
c
+OSCE
d
) in the 
fourth year) 
National 
Board exam 
Korea 
(2+4 Pharmacy 
programme) 
Primary school Junior High 
school 
High school 2-year  
Pre-pharmacy  
+ PEET
e 
 
4-year School of Pharmacy, 
including clerkship in the final 
year; -IPPE
a
 2 credits (70 
hours);APPE
b
 1 years (33 
weeks/1330 hours for 28 
credits) 
National 
Board exam 
Pakistan 
(5-year PharmD) 
Primary school Secondary 
school (lower 
level G6-8) 
Secondary school 
(upper level G9-12) 
5-year PharmD (There is no clarity 
regarding pharmacy practice 
experience) 
 
N/A 
Thailand 
(6-year PharmD) 
Primary school 
(6-11 years old: Prathom) 
High school 
(12-18 years old: Mattayom) 
6-year PharmD, including 2,000 practice hours 
-IPPE
a
 400 hours during the fourth year 
-APPE
b
 1,600 hours during the fifth and the sixth 
year 
National 
Licensure 
exam 
  a
IPPE=Introductory Pharmacy Practice Experience; 
b
APPE=Advanced Pharmacy Practice Experience; 
c
CBT=Computer based testing-for knowledge; 
d
OSCE=(Objective 
Structured Clinical ability Examination)-for professional skills; 
e
PEET=Pharmacy Education Eligibility Test 
Supapaan T, Low BY, Wongpoowarak P, Moolasarn S, Anderson C. A transition from the BPharm to the PharmD degree in five 
selected countries. Pharmacy Practice 2019 Jul-Sep;17(3):1611.  
https://doi.org/10.18549/PharmPract.2019.3.1611 
 
www.pharmacypractice.org (eISSN: 1886-3655 ISSN: 1885-642X) 4 
and colleges of pharmacy revised their curricula in order to 
receive accreditation. 
Enablers 
1) Leadership: The close association between the AACP and 
ACPE played a vital role in the strength of the AACP’s 
suggestions. The AACP influenced the ACPE to revise 
accreditation standards for all school of pharmacy to 
include the PharmD degree and the educational elements 
necessary for providing pharmaceutical care.38,39     
2) Evidence of support: Between 1986-1991, many articles 
focused on the important of preparing pharmacists for the 
changing of the pharmacy profession by shifting towards a 
more comprehensive patient-focused care and other 
factors that stimulated a need for change in pharmacy 
education, particularly the rising cost of health care.19,35,39-
41 There were also a number of studies regarding 
measuring the effect of the PharmD graduates in practice, 
compared to the Bachelor of Science in Pharmacy 
programmes. The conclusions that might be drawn from 
these studies were as follows: job activities and 
professional satisfaction of BPharm and the entry-level 
PharmD graduates were not significantly different.34,42 
However, most of the studies were limited in their 
methodology due to such issues as low response rates and 
imbalanced representation by degrees.7,34  
Barriers 
The barriers that have been mentioned are as the follows: 
1) lengthening the education programme for a year would 
cost money. Tuition fees would increase, student debt 
would rise, and the state would have to contribute more 
funding to support the programme.27 2) there would be a 
lack of competent preceptors.43 
The U.S. PharmD curriculum 
Compared to the BPharm, the PharmD curriculum was 
extended by one year that included additional 
pharmacotherapy and patient care coursework, plus 
expanded experiential learning with specified activities 
emphasising clinical skills; for example, counselling patients 
or advising other health professionals on drug use 
issues.44,47-49  Even though the transition from the BPharm 
to the PharmD programme in the U.S. has been 
accomplished, the American College of Clinical Pharmacy 
(ACCP) and the American Society of Health-System 
Pharmacists (ASHP) think that the pharmacy education 
should be better. Both organisations share a common 
vision that all pharmacists who are involved with direct 
patient care will be required to complete a residency prior 
to entering practice by 2020.50 
 
JAPAN  
Need for the change 
The curriculum change was made to address the strong 
demand for highly competent pharmacists to deliver 
pharmaceutical care for the health care teams.51   
Process of the transition to the PharmD degree 
Changing to a 6-year pharmacy degree programme was 
proposed by the Japan Pharmaceutical Association (JPA) in 
1973. However, the change was not implemented until 
2003, when the Council for Pharmaceutical Education 
approved the transition.52 In 2006, the pharmacy education 
system in Japan was in transition from the traditional 4-
year programme into two programmes, namely: a 
traditional 4-year programme and a new 6-year Bachelor of 
Pharmacy programme, which is similar to the PharmD 
programme.51,52 The traditional 4-year programme 
emphasised pharmaceutical sciences due to the career 
decisions of graduates; approximately 80% of Japanese 
pharmacy graduates enter the pharmaceutical industry.31 
The 4-year BPharm graduates are not able to obtain a 
national pharmacy license.53 The 6-year programme is 
mandatory for registration for the licensure examination 
and is related to the accreditation system.54 Thus, only the 
graduates from the new 6-year programme are able to 
obtain a national pharmacy license.51  
Enablers 
There is a prescription law that separates prescribing and 
dispensing in Japan (Bungyo).28,55 This law allows 
opportunities for pharmacists to   provide pharmaceutical 
care activities within the scope of the prescription law.31,57 
Barriers 
The transition to the 6-year programme in Japan has also 
had many challenges. Those challenges include insufficient 
numbers of academic staff in the clinical pharmacy area; 
lack of experienced preceptors; barriers to providing clinical 
pharmacy activities due to a high volume of prescriptions; 
and other health care professionals still having doubts 
about the role of pharmacists.30 
The PharmD curriculum 
The 6-year programme provides students with more 
pharmaceutical care, pharmacy practice, and 
pharmacotherapy courses. It includes 2.5 month rotations 
in hospital and community pharmacy settings, which are 
longer than the 4-year programme that included only 2-4 
week hospital pharmacy rotation.30 
 
SOUTH KOREA 
Need for the change 
The curriculum changes in the Republic of Korea (South 
Korea) was made to address the significant change in 
pharmacy practice, since a new prescription law was 
enacted in 2000.15 The new law completely separates the 
prescribing and dispensing functions between physicians 
and pharmacists. These conditions were aimed to address 
certain public health issues; in particular, high rates of drug 
misuse and overuse.57 However, pharmacists’ compliance 
with their new roles has been suboptimal. This result is 
because of the 4-year BPharm programme had mainly 
focused on the pharmaceutical sciences and most 
graduates had inadequate preparation to equip them to 
provide clinical services.15 
Process of the transition to the PharmD degree 
In order to cope with the scope of Korean pharmacy 
practice and align with the global trend toward 6-year 
pharmacy programmes, the Ministry of Education and 
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Human Resources Development of Korea reorganised the 
pharmacy programme in 2005.15,20 The transition from the 
4-year programme to the 6-year programme was fully 
implemented in 2009.20 
Enablers 
According to the new situation regarding prescription, 
Korean pharmacists are required to perform drug use 
evaluation and medication counselling for a patient prior to 
dispensing.15 
Barriers 
There is the need to build infrastructure for the pharmacy 
practice experiences such as networking with training sites 
and preceptors. There is also a need to develop facilities 
and resources; in particular funds, manpower and 
knowledge.58  
The PharmD curriculum 
The new curriculum includes a 2-year pre-pharmacy course 
and 4 years of pharmacy with practice experience.15,59 
 
PAKISTAN  
Need for the change 
There were two main motivations for the transition to a 
PharmD programme in Pakistan.60 The first motivation was 
to provide a way for future graduates to practice in the 
U.S.; second was to develop the new curriculum to prepare 
the future pharmacist to have the capacity to work in 
various careers in Pakistan, especially in the patient care 
area.21,60,61 
Process of the transition to the PharmD degree 
In 2004, the Higher Education Commission (HEC) of 
Pakistan upgraded the 4-year BPharm to the 5-year 
PharmD programme in order to standardise the Pakistani 
pharmacy educational system, according to international 
education and practice needs.60,62 It had been announced 
that the 5-year PharmD was the essential condition for a 
university’s PharmD accreditation, and a requirement for a 
pharmacist to practice in Pakistan.60 
Enablers 
The government hired a broad range of pharmacists in 
major public hospitals in order to establish and provide 
pharmaceutical services and to serve as training sites for 
the PharmD graduates in the future.21 
Barriers 
There were concerns about an inadequate number of 
experienced and qualified academic staff in the pharmacy 
practice area, lack of practice based-settings, as well as the 
insufficient clinical content and practice training in the 
PharmD programme, all of which may lead to low quality of 
education and low student satisfaction and 
performance.18,24,60,62,63 Secondly, there are many 
challenges for PharmD graduates in practice; for example, 
lack of an acceptance by other health professionals, the 
dispenser in pharmacies and hospitals performing the 
pharmacists’ jobs; lack of the public awareness of the 
pharmacists’ roles, and a severe pharmacy workforce 
shortage.4,60,62,64,65 
The 5-year PharmD curriculum 
The 5-year PharmD programme had increased content and 
practice in pharmaceutical care and the clinical pharmacy 
clerkship. However, there were reports that the clinical and 
social aspects of pharmacy; in particular patient 
counselling, research methods and evidence-based 
medicines, as well as other major areas (e.g., public health 
pharmacy and drug policy) were not included in the new 
curriculum.10,60,66 
 
THAILAND 
Need for the change 
Thai policy makers believed that a transition to the 6-year 
PharmD would meet the needs of the stakeholders by 
changing pharmacy competencies from generalists to 
specialists, resolve the issue of curriculum overload for the 
high-credit 5-year BPharm programme, and produce equal 
educational standards and outcomes and for the pharmacy 
profession on a national level.67  
Process of the transition to the PharmD degree 
Enablers 
An important influence that has been mentioned on the 
transition to an all-PharmD programme in Thailand was the 
cooperation of four faculties of pharmacy and the Bureau 
of Health   Service System Development, Ministry of Public 
Health (MoPH), in the development and   establishment of 
a master’s degree in clinical pharmacy via a modular system 
programme. This foundation of clinical pharmacy activities 
in real workplace settings was supported by the U.S.-Thai 
consortium for the development of pharmacy education in 
Thailand, which was founded in May 1994 by the Pharmacy 
Education Consortium of Thailand (PECT). Another big drive 
for advancement came from the announcement of the 
Pharmacy Council of Thailand (PCT) in 2008 that, starting in 
2014, all new pharmacy graduates who are able to enter 
national pharmacy license examination would have to 
graduate from pharmacy faculties accredited by the Council 
through the 6-year PharmD curriculum only.67 
Barriers 
There were concerns about the higher costs of a longer 
period of time for study and an insufficient quantity and 
varying quality of PharmD preceptors and training sites.67 
The 6-year PharmD curriculum 
There are three tracks of PharmD in Thailand which are as 
follows; the pharmaceutical care PharmD which focused on 
patient care; the industrial pharmacy PharmD which is 
pharmaceutical product oriented, and the health consumer 
protection which focused on consumer protection 
mechanism regarding pre-marketing control, post-
marketing control and consumer empowerment.68-70 
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Table 3. Key points summarising the transition from the BPharm to the PharmD degree or similar programmes in term of need, process and perceived barriers in the five selected countries. 
 US
19,38,43,45,52
 Japan
30,51,52,54
 South Korea
15,20,58,74
 Pakistan
21,33,60-62
 Thailand
81,82
 
Need for the transition  To have a highly skilled clinical 
pharmacist to provide the 
pharmaceutical care and work 
with health care teams 
To cope with the regulations that 
changes in the scope of 
pharmacy practice in their 
countries 
To cope with the regulations that 
changes in the scope of pharmacy 
practice  
To standardise the Pakistani 
pharmacy educational system 
and enable the graduates to 
work abroad  
The 6-year PharmD will produce 
pharmacy graduates who had 
knowledge and skills needed by the 
job market. 
Previous   programme  5-year Bachelor  4-year BPharm 4-year BPharm 4-year BPharm 5-year BPharm 
New programme 6-year PharmD (PC
a
) 6-year BPharm (PC
a
) 6-year programme (PC
a
, IP
b
) 5-year PharmD (PC
a
, IP
b
) 6-year PharmD (PC
a
, IP
b
, CP
c
) 
The difference  
between the previous 
and the 6-year 
curriculum 
PharmD curricula were extended 
by one year that includes 
additional patient care 
coursework  
The new 6-year BPharm           
programme focused on patient 
care. 
The new programme increases the 
number of required courses in 
clinical pharmacy and training 
period. 
Increase knowledge and 
practice in pharmaceutical care 
and the clinical pharmacy 
clerkship  
The 6-year PharmD increased 
practice hours.  
Process of transition In 1997, the ACPE
c 
decreed that 
they would no longer accredit 
BPharm programmes in 2000 
and all schools of pharmacy had 
to convert to the PharmD as the 
sole professional degree. 
Proposed by the JPA
e
 in 1973 and 
approved by the Council for 
Pharmaceutical Education in 
2003.  
The Ministry of Education and 
Human Resources Development of 
Korea reorganised the pharmacy 
programme in 2005. The new 
programme was fully implemented 
in 2009. 
In 2004, the HEC
f
 of Pakistan 
upgraded the 4-year BPharm to 
the 5-year PharmD programme 
in 2004.  
Proposed by the PECT
g
 and it was 
mandated by the PCT
h
 for pharmacy 
licenses in 2008. All schools moved 
to the 6-year   programme in 2010. 
Perceived barriers  Difficulties to provide adequate 
numbers of hospital-based 
preceptors. 
Inadequate number of academic 
staff in clinical pharmacy and 
qualified preceptors. 
There is need to build     
infrastructure for pharmacy   
practice experiences.  
Limitations in pharmacy   
education and limitation of 
pharmacists’ roles in clinical 
settings  
Lack of long-term strategies for 
reasonable implementation  
a
PC = Pharmaceutical care; 
b
IP = Industrial pharmacy; 
c
CP = Consumer Protection; 
d
ACPE = Accreditation Council on Pharmaceutical Education; 
e
JPA = the Japan Pharmaceutical Association; 
f
HEC=Higher Education Commission; 
g
PECT = Pharmacy Education Consortium of Thailand; 
h
PCT = Pharmacy Council of Thailand 
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CONCLUSIONS 
Each country has different needs due to the different 
contexts of health care systems that are related to the 
scope of pharmacy practice. The countries should consider 
their needs critically before they decide to adopt the 
PharmD programme, in order to increase and ensure the 
benefits they will get from the new programme. Each 
country created a different process to handle the transition 
to an all-PharmD programme, but mostly had the process 
of school accreditation mandated by the appropriate 
regulatory bodies (Table 3). The barriers to the transition in 
most of countries are insufficient numbers of academic 
staff and preceptors in the clinical pharmacy area; 
insufficient experienced preceptors and training sites; 
barriers to providing clinical pharmacy activities in some 
countries due to a high volume of prescriptions and 
pharmacy workforce shortage.18,28,52,54,55,58,60,62,63,67 Finally, 
there still needs to be a framework or a set of indicators to 
measure and monitor the impact/outcome of the PharmD 
degree. This set of indicators should be used as a feedback 
loop to evaluate whether the transition balances the 
impacts/outcomes that meet the needs of the adopting 
country. 
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